Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALPINE: Aliskiren in Established Atherosclerosis
NCT01417104Phase 3Terminated
- Sponsor
- The Ohio State University
- Start
- Oct 2009
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aliskiren in atherosclerosis, sponsored by The Ohio State University. Started Oct 2009; status: terminated.
02
Drugs
aliskiren
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT01417104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01417104.